0.55%| Prev Close: | 213.78 |
|---|---|
| Open: | 212.76 |
| Bid: | 212.57 x 100 |
| Ask: | 212.62 x 700 |
| NAV¹: | 86.70 |
| Net Assets²: | 3.55B |
| YTD Return (Mkt)²: | 41.25% |
| Day's Range: | 212.17 - 213.73 |
|---|---|
| 52wk Range: | 125.63 - 213.78 |
| Volume: | 235,409 |
| Avg Vol (3m): | 682,712 |
| P/E (ttm)²: | 26 |
| Yield (ttm)²: |
¹As of Nov 29, 2012
²As of Aug 30, 2013
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Health Care and Biotech ETFs Brace for Obamacareat Minyanville(Tue, Oct 1)
- Today's Market: What To Buy While Washington Is Shut Downat Seeking Alpha(Tue, Oct 1)
- ETF Categories That Just Keep On Winningat Seeking Alpha(Mon, Sep 30)
- iShares Nasdaq Biotechnology ETF Experiences Big Outflowat Forbes(Mon, Sep 30)
- Shutdown Threat Sends Stocks Lowerat Forbes(Mon, Sep 30)
- Knowing When To Be An Optimist, A Dreamer, Or A Realist In Biotech Investing Can Make All The Differenceat Seeking Alpha(Sat, Sep 28)
- Best ETF Buys Vs. Best Buys Of 2529 Forecasts From Market-Maker Hedgingat Seeking Alpha(Fri, Sep 27)
- Biotech The Equal-Weight WayETF Trends(Wed, Sep 25)
- Stocks Try To Snap Losing Streak, Apple Inches Toward $500 Againat Forbes(Tue, Sep 24)
- Stocks Struggle For Footing, Apple Sprints Higherat Forbes(Mon, Sep 23)
- Biotech ETFs: Outstanding Risk-Adjusted Portfoliosat Seeking Alpha(Sun, Sep 22)
- Top Biotech Stock Picks for Q4 2013: An Interview with Boris Peaker, Executive Director and Senior Analyst at Oppenheimer & Co. Inc.Wall Street Transcript(Fri, Sep 13)
- IBB, CELG, BIIB, REGN: ETF Inflow Alertat Forbes(Thu, Sep 12)
- Biotech ETFs Among 2013 Best PerformersIndexUniverse.com(Thu, Sep 12)
- The Smartest Way To Play The Booming Biotech Sectorat Seeking Alpha(Tue, Sep 10)
Reports
- IBB: Fundamental Valuation and Predictive Rating ReportNew Constructs, LLC(Oct 2)
- ValuEngine Industry Report for Finance-public TD INV FDValuEngine, Inc.(Oct 2)
- ISHARES NASDAQ BIOTECHNOLOGY I (IBB) 12-months forecastPechala's Reports(Sep 28)